RSCM
IMGN

Rock Springs Capital Management’s Immunogen Inc IMGN Stock Holding History

Rock Springs Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-759,365
Closed -$22.5M – 119
2023
Q4 		$22.5M Hold
759,365
– – 0.55% 53
2023
Q3 		$12.1M Buy
759,365
+646,745
+574% +$10.8M 0.32% 68
2023
Q2 		$2.13M Buy
+112,620
New +$1.33M 0.05% 106

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Rock Springs Capital Management's IMGN Position: Q1 2024 in Review

Rock Springs Capital Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 759,365 shares — an estimated $22.5M sold.

Rock Springs Capital Management first reported a position in IMGN in Q2 2023 and held it in 3 quarters. The position peaked at $22.5M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Rock Springs Capital Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Rock Springs Capital Management sold 759,365 Immunogen Inc shares in Q1 2024, an estimated $22.5M.
  • Rock Springs Capital Management first reported a position in Immunogen Inc in Q2 2023 and held it in 3 quarters.
  • Rock Springs Capital Management's Immunogen Inc position peaked at $22.5M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Rock Springs Capital Management's 13F filing for Q1 2024, filed 15 May 2024.